XGN
EXAGEN INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$8.51
+2.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.61x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 16.88x
- Price / sales
- 2.90x
- Price / cash flow
- -31.73x
Enterprise value
- Enterprise value
- $207.1M
- EV / sales
- 2.91x
- EV / EBITDA
- -18.30x
- EV / EBIT
- -15.68x
- Market cap
- $206.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026